Cancer type | Target genes | Biological function | References |
---|---|---|---|
Tumor suppressor | |||
 Breast cancer | SMAD2 | Inhibiting invasion and metastasis | [12] |
SOX9 | Enhancing endocrine therapy sensitivity | [24] | |
STC2, PAR1 | Inhibiting migration and angiogenesis | ||
 Cervical cancer | – |  | [23] |
LNMICC | Inhibiting metastasis | [26] | |
 Colon cancer | HGF, VEGF, JAK2, RAS, SMAD2 | Inhibiting angiogenesis | [27] |
 Glioma | MEF2C | Inhibiting proliferation, migration, and invasion and promoting apoptosis | [20] |
– | Inhibiting tumor growth | [28] | |
 Hepatocellular carcinoma | treRNA | Inhibiting migration and invasion | [19] |
 Prostate cancer | YB1 | Inhibiting proliferation | [21] |
 Rectal cancer | – |  | [22] |
Oncogene | |||
 Gastric cancer | FOXP2 | Promoting proliferation, migration and invasion | [18] |
 Prostate cancer | PHLPP1 | Promoting migration and invasion | [29] |
 Hepatocellular carcinoma | PHLPP1 | Promoting proliferation, migration and invasion | [30] |